Article

Detection of cytomegalovirus in human placental cells by polymerase chain reaction

Center for Medical Biology, Polish Academy of Sciences, Laboratory of Molecular Virology and Biological Chemistry, Lódź, Poland.
Apmis (Impact Factor: 1.92). 12/2006; 114(11):764-71. DOI: 10.1111/j.1600-0463.2006.apm_31.x
Source: PubMed

ABSTRACT Human cytomegalovirus (HCMV) is the most common cause of viral intrauterine infection. Progress in rapid, specific, and dependable detection of HCMV has recently been achieved by the use of DNA hybridization techniques and other molecular methods. We examined 21 placentas after delivery for the presence of HCMV DNA by polymerase chain reaction (PCR). To test the reliability of the PCR for the detection of HCMV DNA in clinical specimens, two simple PCR assays and a real-time quantitative PCR were used. PCR analysis of villous and decidual cells showed that HCMV DNA was present in 16 placentas (76.2%). Transmission of HCMV infection to chorionic villi was confirmed in 11 organs (52.4%), and congenital infections in newborns were detected in 9 cases (42.8%). These results suggest that HCMV genome detection in placentas at later gestational ages is common. Our results demonstrated that detection of HCMV DNA in placental tissues by DNA amplification provides a specific and sensitive method for diagnosis of intrauterine HCMV infection.

Download full-text

Full-text

Available from: Zbigniew J Lesnikowski, Jun 30, 2014
0 Followers
 · 
95 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cytomegalovirus (CMV) is the leading cause of congenital infections among neonates. About 10% of newborns with such an infection have clinical symptoms at birth and about 1% of infected fetuses die due to developmental malformations. Mannan-binding lectin (MBL) is considered to be an important factor in innate immunity. Its deficiency is believed to predispose to various (including viral) infections. The aim of this study was to investigate the possible role of MBL2 gene polymorphisms in prenatal and perinatal CMV infections. The frequencies of MBL2 gene exon 1 mutations as well as MBL deficiency-associated variants (LXPA/O+O/O) among newborns with confirmed cytomegalovirus infection were not significantly lower than among non-infected individuals. The distribution of MBL2 haplotypes was similar between the groups studied. These data suggest MBL does not have a major influence on susceptibility to prenatal or perinatal CMV infections.
    Molecular Immunology 06/2011; 48(15-16):2203-6. DOI:10.1016/j.molimm.2011.06.220 · 3.00 Impact Factor
  • Conference Paper: The Italian 2003 blackout
    [Show abstract] [Hide abstract]
    ABSTRACT: On September 28th, 2003, at 3:01 a.m., a fault on the Swiss power system caused the overloading of two Swiss internal lines close to the Italian border. The interconnection lines were heavily loaded by the large power import and the coordination between the system operators was not sufficient to mitigate the overload. The consequent loss of those important branches caused cascading outages of the lines interconnecting the Italian system and the remaining part of the UCTE (Union for the Coordination of the Transmission of Electricity) system. This resulted in a very sudden loss of synchronism between the Italian system and the UCTE grids, causing the loss of the whole import. The consequent power unbalance caused the frequency in Italy to decline; the automatic load shedding procedure was not able to shed load enough to balance the generation and the load, and this resulted in the blackout. The paper provides a short description of the pre-fault system operation and of the main events that triggered the blackout, identifying some of the main causes that resulted in the separation of the Italian system and the blackout. In addition, issues related to the misoperation of the Italian automatic procedure to prevent the blackout are discussed.
    Power Engineering Society General Meeting, 2004. IEEE; 07/2004
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: MicroRNAs (miRNAs) can be defined as small, noncoding sets of 19 to 24 nucleotides that have been associated with messenger RNA expression. miRNAs are members of a class of small regulatory RNAs that includes small interfering RNAs (siRNAs). miRNAs regulate the expression of downstream gene targets, including transcription factors, oncogenes, and tumor suppressor genes. Transcriptional profiling using genomic microarrays and beads has enabled the discovery of numerous miRNAs that are differentially expressed in normal tissues vs tumors and associated with cancer development, diagnosis, and prognosis. miRNA signatures can be used to detect and classify cancer and predict the severity of disease, with certain profiles of miRNA expression linked to aggressive cancers with advanced disease present at diagnosis. miRNAs have also become targets of novel anticancer gene therapy with antisense molecules that can inhibit miRNA activity currently being tested for their efficacy in a strategy of reducing miRNA activity on reporter genes bearing miRNA-binding sites. In the future, sophisticated genomic and proteomic techniques combined with complex bioinformatics data analyses will be required to translate these recent basic science discoveries to clinically useful diagnostic tests.
    American Journal of Clinical Pathology 12/2007; 128(5):830-6. DOI:10.1309/2JK279BU2G743MWJ · 3.01 Impact Factor